The Effect of Botulinum Toxin Injection at Hip Adductor Muscles in Patients With Spastic Cerebral Palsy, Pilot Study
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cerebral Palsy
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 2 years and 10 years
- Gender
- Both males and females
Description
Design: Prospective study Inclusion criteria of patient group: who has a cerebral palsy and GMFCS level 3,4,5 Intervention: applied medication Botulinum A injection (meditox 200unit) Main outcome measures: The investigators will measure for finding evidence by checking the x-ray photograph, hip addu...
Design: Prospective study Inclusion criteria of patient group: who has a cerebral palsy and GMFCS level 3,4,5 Intervention: applied medication Botulinum A injection (meditox 200unit) Main outcome measures: The investigators will measure for finding evidence by checking the x-ray photograph, hip adductor and muscles pressure test and electromyography(EMG test) test of hip adductor, abductor and spine muscles.
Tracking Information
- NCT #
- NCT03680196
- Collaborators
- Not Provided
- Investigators
- Study Director: Jusuk Ryu Seoul National University Bundang Hospital